SIMRIS ALG AB B
Simris Group AB (PUBL) develops, manufactures, and sells bioactive substances from microalgae in Sweden and internationally. It offers skincare products and pharmaceuticals; food ingredients; and Algae Omega-3, an omega-3 EPA and DHA line under the SIMRIS brand name. The company was incorporated in 2011 and is headquartered in Hammenhög, Sweden.
SIMRIS ALG AB B (5LU) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, SIMRIS ALG AB B (5LU) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
SIMRIS ALG AB B - Net Assets Trend (None–None)
This chart illustrates how SIMRIS ALG AB B's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for SIMRIS ALG AB B (None–None)
The table below shows the annual net assets of SIMRIS ALG AB B from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to SIMRIS ALG AB B's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
SIMRIS ALG AB B Competitors by Market Cap
The table below lists competitors of SIMRIS ALG AB B ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Altur Slatina
RO:ALT
|
$1.58 Million |
|
Catheter Precision Inc.
NYSE MKT:VTAK
|
$1.58 Million |
|
Viver Incorporadora e Construtora S.A
SA:VIVR3
|
$1.59 Million |
|
BOSTON BEER -A-
BE:BBEA
|
$1.59 Million |
|
Visioneering Technologies Inc
AU:VTI
|
$1.58 Million |
|
HIGH QUALITY FOOD
F:L24
|
$1.58 Million |
|
UTD TECHNOLOGIES
HM:UTC1
|
$1.58 Million |
|
0F5A
LSE:0F5A
|
$1.58 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SIMRIS ALG AB B's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares SIMRIS ALG AB B's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently SIMRIS ALG AB B utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares SIMRIS ALG AB B's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $1,291,084,078
- Average return on equity (ROE) among peers: -24.49%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SIMRIS ALG AB B (5LU) | €- | N/A | N/A | $1.58 Million |
| 09R (09R) | $-3.01 Million | 0.00% | 0.00x | $11.12 Million |
| IDORSIA AG (19T) | $-968.72 Million | 0.00% | 0.00x | $532.51 Million |
| 1S90 (1S90) | $-44.86 Million | 0.00% | 0.00x | $51.72 Million |
| Strategic Partners A/S (1TB0) | $14.24 Million | -182.90% | 0.36x | $1.31 Million |
| 25K0 (25K0) | $-16.66 Million | 0.00% | 0.00x | $102.39 Million |
| 2BO (2BO) | $-37.78 Million | 0.00% | 0.00x | $6.23 Million |
| Intervacc AB (publ) (2E9) | $237.93 Million | -43.23% | 0.09x | $3.46 Million |
| 2F5 (2F5) | $-4.57 Million | 0.00% | 0.00x | $2.14 Million |
| 2H0 (2H0) | $14.92 Million | -17.30% | 0.56x | $9.25 Million |
| GNI Group Ltd (3G6) | $13.72 Billion | -1.46% | 0.26x | $772.60 Million |